Wednesday August 25, 2004

Medical Journals Censor Information on Abortion - Breast Cancer Link

Recognition of abortion-breast cancer link could embarrass researchers and cancer fundraising industry

CHICAGO, August 25, 2004 (LifeSiteNews.com) - The Coalition on Abortion/Breast Cancer, an international women's organization that disseminates information on abortion as a risk factor for breast cancer, deplored the censorship of important scientific research by two medical journals. "Recognition of the [abortion-breast cancer] link could embarrass leading researchers and the cancer fundraising industry," explained Karen Malec, president of the coalition. "Nevertheless, the increasing incidence and importance of female breast cancer merits the fullest scientific investigation and discussion," she added.

Refusing to publish letters from leading medical researchers were a UK journal, The Lancet, and Cancer Epidemiology, Biomarkers & Prevention, the main publication of the American Association for Cancer Research.

The Lancet refused to publish letters from two experts, Chris Kahlenborn, MD and Patrick Carroll. Kahlenborn is the author of Breast Cancer: It's Link to Abortion and the Birth Control Pill. Carroll is a British actuary and statistician and the research director for the Pension and Population Research Institute in London.

Cancer Epidemiology, Biomarkers & Prevention rejected a letter from Joel Brind, Ph.D., professor of endocrinology at Baruch College, City University of New York. Summaries of the censured letters can be accessed at http://www.abortionbreastcancer.com/letters/index.htm

jmo

URL: http://www.lifesitenews.com/ldn/2004/aug/04082503.html

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.